What question did this study set out to answer?

The report aims to highlight the occurrence of Kaposi sarcoma as a complication associated with mogamulizumab treatment in specific lymphoma patients.

February 12, 2026JAMA Dermatology1 citations

Mogamulizumab-Associated Kaposi Sarcoma in 2 Patients With Primary Cutaneous T-Cell Lymphomas

View Full Paper

EHE. HolderHospices Civils de Lyon SBSamy BelkaïdHospices Civils de Lyon CWChloé WirbelHospices Civils de Lyon

Key Points

The report aims to highlight the occurrence of Kaposi sarcoma as a complication associated with mogamulizumab treatment in specific lymphoma patients.
Case report on two patients experiencing treatment effects
Clinical assessments documented under standard protocols
Both patients developed Kaposi sarcoma following mogamulizumab treatment
Findings suggest a potential link between immunotherapy and skin cancer development

Abstract

This case report describes mogamulizumab-associated Kaposi sarcoma in 2 patients with primary cutaneous T-cell lymphomas.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Holder et al. (Wed,) studied this question.

synapsesocial.com/papers/698d6edc5be6419ac0d54b35 https://doi.org/https://doi.org/10.1001/jamadermatol.2025.5565

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark

View Full Paper